Intervooh · Interview questions by job · Science & Pharma
Clinical Research Associate interview questions (2026)
Clinical Research Associate interviews in the UK are assessed on ich-gcp compliance, monitoring rigour & data integrity, site relationship management, usually across 3 stages — phone or video screen, then panel interview, then technical interview or test. The 12 questions below are the ones actually asked, each with what a strong answer does.
Researched, current questions asked in real clinical research associate interviews in the UK (Science & Pharma), with what a strong answer actually does. Questions marked 2026 are the newer, AI-era questions employers now ask. Last reviewed 2026-07-22.
Build my free day-by-day prep plan →
Tell it the company, role and date; it does the rest. Free, no card.
What they assess
- ICH-GCP compliance
- Monitoring rigour & data integrity
- Site relationship management
- Organisation across sites
- Problem-solving & escalation
How a clinical research associate interview usually runs
- Phone or video screen
- Panel interview
- Technical interview or test
The questions to expect
What do you check on a routine monitoring visit, and how do you decide where to focus your source data verification?
Consent first, then safety data, eligibility, drug accountability, delegation log — with risk-based focus on what matters most to patient safety and endpoints.
You find a protocol deviation at a site — a subject dosed outside the window. What do you do?
Assess subject safety impact, document it, ensure the site reports per protocol/sponsor SOPs, root-cause it and prevent recurrence. Never minimise or bury it.
How do you make sure informed consent at your sites is genuinely informed — not just signed?
Right version signed before any procedure, process documented, staff trained, re-consent after amendments — and checking the conversation happened, not just the ink.
A site is falling behind on recruitment and data entry, and the coordinator has stopped answering your emails. What do you do?
Pick up the phone, find the real blocker (workload, staff turnover, protocol friction), agree an action plan, escalate to the PI and sponsor if it persists. Partnership first.
You suspect data at a site may have been fabricated or backdated. Walk us through your response.
Don't confront or accuse: secure the evidence, document objectively, escalate immediately to your line manager and sponsor QA per SOP. This one is a pass/fail question.
How do you keep multiple sites, visit reports and follow-up letters on track while travelling?
Your actual system: visit-report deadlines met on the train home, tracker discipline, protected admin days. Report timeliness is how CRAs get judged — say your numbers.
Tell us about a difficult conversation with an investigator or site staff member — and how the relationship survived.
Facts not blame, the site's pressures acknowledged, compliance still non-negotiable. CRAs who can challenge warmly are the ones sponsors keep.
Why clinical research — and why monitoring rather than staying at the bench or the site?
Patients-at-scale is the honest draw: your rigour protects trial subjects and future patients. Show you know the travel and autonomy realities too.
Risk-based and remote monitoring, decentralised trials, eSource — how have these changed the CRA's job, and how do you work in that model?2026
Centralised data review targets your on-site time at the riskiest signals — name the systems you've used (EDC, CTMS, eTMF) and how you monitor remotely without losing the site relationship.
What does good documentation look like in a lab or trial — and why does it matter so much?
ALCOA in your own words: attributable, legible, contemporaneous, original, accurate. Then the habit — recording in real time, never backfilling.
Tell us about a time your results didn't match what you expected. What did you do?
The scientific reflex: check the method and instrument before doubting the sample, repeat with controls, report honestly. Unexpected results aren't failures.
What do you do if an SOP seems wrong, outdated or impossible to follow as written?
Never silently deviate: flag it through the change/deviation process, follow the current version meanwhile unless it's unsafe. Compliance plus initiative.
How to prepare for a clinical research associate interview in the UK
Expect scenario questions over definitions — deviation handling, consent, a difficult site — anchored in ICH-GCP. UK trials also run under MHRA regulation; CRO interviews often add a case exercise reviewing a mock visit report or data listing.
How Science & Pharma interviews are run in 2026
- Lab and scientist roles combine a competency panel with a technical round — often a lab tour, a practical task or presenting your own work; regulated (GMP/GCP) roles probe data integrity hard.
- Pharma and CRO interviews are scenario-based: expect 'what would you do if a result was out of specification / a site deviated from protocol' rather than definition recall.
- First rounds are commonly video calls; NHS lab roles (biomedical science) follow structured values-based panels with HCPC registration checks.
Turn this into a plan
A list of questions is a start; a programme is what changes the outcome. Intervooh builds a day-by-day plan for your exact clinical research associate interview — company research, story building with an AI coach, spoken practice with delivery feedback, and scored mock interviews. It never writes your answers for you.
Related Science & Pharma roles
- Biomedical Scientist interview questions
- Chemist interview questions
- Laboratory Technician interview questions
- Microbiologist interview questions
- Research Scientist interview questions